hackettg

Following representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of the following nine unlicensed medicines listed in Part VIIIB of the Drug Tariff from 1 November 2022: Ciprofloxacin 0.3% ear drops (10ml) Clonazepam 2.5mg/ml drops (10ml) Coal tar 10% ointment (100g) Coal tar 5% ointment (100g) [...]

The post Nine Part VIIIB specials reclassified as special containers from November 2022 appeared first on PSNC Website.

PSNC Dispensing and Supply Team has collaborated with the Neonatal and Paediatric Pharmacists Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH) to get some Specials listings in the Drug Tariff amended, following concerns over patient safety. Pharmacist Steve Tomlin, the Director of the Children’s Medicines Centre at Great Ormond Street Hospital, [...]

The post Paediatric specials listed in Tariff updated appeared first on PSNC Website.

Drug alert number: EL (22) A/46 Date issued: 27th October 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Mebeverine hydrochloride 135mg Film-coated tablets (Medreich PLC) – PL 21880/0247 Batch Number Expiry Date Pack Size First Distributed B11539 11/2024 100 tablets 25 August 2022 Active Pharmaceutical Ingredient: [...]

The post Class 3 Medicines Recall: Mebeverine hydrochloride 135mg Film-coated tablets appeared first on PSNC Website.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 November 2022. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. § Selected [...]

The post Drug Tariff Watch – November 2022 appeared first on PSNC Website.

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Targocid 200mg powder for solution for injection/infusion or oral solution, Aventis Pharma Limited t/a Sanofi, due to the presence of bacterial endotoxins. National Patient Safety Alert Reference Number: NatPSA/2022/008/MHRA Date issued: 21st October 2022 Targocid 200mg powder for solution for injection/infusion or oral solution [...]

The post National Patient Safety Alert: Class 1 Medicines Recall Notification: Targocid 200mg powder for solution for injection/infusion or oral solution appeared first on PSNC Website.